All News

Patients with relapsed diffuse large-B cell lymphoma had monthly healthcare costs of $6566.

Genetically engineered T cells show efficacy preventing acute myeloid leukemia relapse.

Novel immunotherapy shows promise treating patients with leukemia at high-risk of relapse.

Patients diagnosed with cancer may be more likely to experience a myocardial infarction.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Studies find varying results in incidence of strokes from wet age-related macular degeneration treatment.

Ocrelizumab achieves primary endpoints treating primary progressive multiple sclerosis.

Immunoregulatory agent sirolimus shows superiority to systemic corticosteroids in noninfectious uveitis.

Claris Injectables, a subsidiary of Claris Lifesciences, put its generic injectables unit up for sale last summer.

Screening tools are needed so that health care professionals can offer immunizations at every convenient opportunity.

Baxter has entered a definitive agreement for the acquisition of India-based Claris Injectables for $625 million.

Currently, the treatment duration of acute otitis media (AOM) is unclear.

There is little evidence on ibuprofen’s impact on birth weight and premature delivery.

As a pharmacist, I’m often asked, “What’s the best pill for sleep?!” Believe it or not, the “best” solution does not lie in a pill.

The National Association of Chain Drug Stores (NACDS) has sent a letter to the governors of all 50 states, urging pharmacy patient care as a top priority in any changes to healthcare policy in 2017 and beyond.

The placenta diverts blood flow away from the brain in fetuses of mothers with diabetes.

Specialty pharmacies have multiple decisions to make for clinical programs that accompany a contract with a manufacturer.

Ocrevus is an investigational, humanized monoclonal antibody that may improve multiple sclerosis treatment.

FDA extends biologics license application review for MS drug ocrelizumab (Ocrevus) to allow for more information on manufacturing process.

Pharmacists have once more been ranked among the most honest and ethical professionals in the United States, according to the results of the latest Gallup poll on the topic.

The ASP0892 vaccine could potentially mitigate severe allergic reactions to peanuts.

Progression free survival more than doubled with niraparib treatment.

Niraparib is an investigational PARP inhibitor currently being evaluated for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancers.

Metastasis affects as many as 5% of cancer patients around the world.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Abbreviated new drug application filed with the FDA for a generic version of Norco (hydrocodone bitartrate and acetaminophen tablets).

The FDA granted orphan drug designation to nintedanib, a triple angiokinase inhibitor, for the treatment of mesothelioma.

Nintedanib combination shows significant clinical benefit treating mesothelioma